Queen's University Chooses Xceed's Ziplex(R) System for Translationa...(eswith an international reputation for s...),Health

Date:9/15/2008

es, with an international reputation for scholarship, research, social purpose, spirit and diversity. The Department of Pathology and Molecular Medicine of Queen's University is affiliated with the University Hospitals Kingston. Its graduate program provides comprehensive training in basic and translational biomedical research and offers residency programs in anatomic, general, and hematopathology. Departmental research programs are focused on the understanding of the molecular pathogenesis of disease and the design and implementation of new therapeutic strategies.

Xceed Media Contact: Caroline Grossman -- 781.771.5579 --

caroline.grossman@gmail.com

Company Contact: Susan Josey -- 972-317-8948 --

sjosey@xceedmolecular.com

'/>"/>

SOURCE Xceed Molecular Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3
Related medicine technology :

1. deCODE and Radboud University Discover Common Variants in the Human Genome Conferring Risk of Bladder Cancer
2. The University of Nottingham in the British Midlands Announces Breakthrough in Parkinsons Disease Research
3. Boston University and The Center for Human Genetics, Inc. Announce Change in Testing Services
4. First U.S. Patient to Receive New Heart-Assist Device Doing Well After Surgery at University of Michigan
5. University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society
6. Terumo Heart Obtains IRB Approval from the University of Michigan to Initiate DuraHeart(TM) Left Ventricular Assist System U.S. Pivotal Trial
7. Orion Genomics Gains Exclusive Worldwide Rights to the IGF2 Gene for Colorectal Cancer Risk Testing Through Licensing Agreement With Johns Hopkins University
8. CellCyte Genetics Corporation Selects Washington University School of Medicine to Perform Study on CellCytes Glycoprotein Products in Heart Attack Disease Model
9. University of Miami Team Confirms Value of Monitoring Cell-Mediated Immunity Pre- and Post-Transplant in Management of Kidney Transplant Recipients
10. Kiadis Pharma Announces Collaboration With the Julius Maximilians University of Wurzburg, Germany
11. CellCyte Genetics Signs Collaborative Agreement With Northwestern Universitys Feinberg School of Medicine to Perform Disease Model Outcome Study of CellCytes CCG-TH30 Product Candidate